GRObio is using its innovative platform and NSAAs to transform treatments in diverse areas, such as autoimmune and metabolic diseases.

Last year Ginkgo Bioworks announced a major AI partnership with Google Cloud to apply large language models to biology, especially focused on proteins.

Synthetic biology is now integrating with the therapeutics industry. Over time, many synthetic biology companies have gravitated toward therapeutics, especially more biologically complex therapies such as biologics (proteins) or cell and gene therapy, where the advanced approaches of synthetic biology may have the highest impact. 

A-Alpha Bio and Amgen have announced an expansion of their collaboration to enable the rational discovery of molecular glues, which could be used to degrade disease-related proteins.

3T Biosciences, a company our team supported in its early days, recently announced its second partnership with Boehringer Ingelheim to discover and develop next-generation cancer therapies.

Dr. Omar K. Farha, founder and Chief Scientific Officer of Numat and Professor of Chemistry at Northwestern University, gave the commencement address to UCLA’s 2023 chemistry graduates.